ELDN
Eledon Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.02
+3.07%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-136.8%
Return on equity
-78.2%
Return on assets
-116.7%
Return on invested capital
0.00x
Asset turnover
-$73.9M
Cash from operations
$1.09
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026